Emerging Drugs and Targets for Multiple Sclerosis
Multiple sclerosis (MS) is a complex disease with a presumed autoimmune aetiology and few current effective treatments. Disease modifying therapies focus on the altering the natural course of relapsing and remitting MS, targeting the inflammatory response. Other targets involve tacking the cause of the disease - demyelination of axons through remyelination therapies. Due to several recent breakthroughs in the understanding of the pathophysiology of MS new targets for remyelination and immunomodulation are rapidly emerging. This book provides a comprehensive overview of drug discovery and development for the molecular basis of the disease, fro…
Mehr
CHF 276.05
Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)
Versandkostenfrei
Produktdetails
- ISBN: 978-1-78801-806-7
- EAN: 9781788018067
- Produktnummer: 31966402
- Verlag: Royal Society of Chemistry
- Sprache: Englisch
- Erscheinungsjahr: 2019
- Seitenangabe: 333 S.
- Plattform: EPUB
- Masse: 5'003 KB
- Auflage: 1. Auflage
8 weitere Werke von Ana (Hrsg.) Martinez:
Bewertungen
Anmelden